PepGen Inc (PEPG)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$3.11-2.20%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · PEPG
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| R&D Expenses | 52.8 | 71.0 | 76.5 | 68.1 | 54.1 | 19.0 | — |
| Operating Income | (76.2) | (93.6) | (97.7) | (84.8) | (68.3) | (27.1) | — |
| Earnings from Continuing Operations | |||||||
| Interest & Investment Income | 4.4 | 4.0 | 7.1 | 6.4 | 2.8 | — | — |
| Other Non-Operating Income / Expenses | 4.4 | 4.0 | 7.1 | 6.2 | 2.9 | (0.2) | — |
| EBT, Incl. Unusual Items | (71.9) | (89.6) | (90.6) | (78.6) | (65.4) | (27.3) | — |
| Income Tax Expense | — | 0.0 | (0.6) | 0.1 | 3.7 | 0.0 | — |
| Net Income | |||||||
| Net Income | (71.9) | (89.7) | (90.0) | (78.6) | (69.1) | (27.3) | — |
| Per Share | |||||||
| Basic EPS | (1.04) | (2.12) | (2.85) | (3.30) | (4.42) | (30.27) | — |
| Diluted EPS | (1.04) | (2.12) | (2.85) | (3.30) | (4.42) | (30.27) | — |
| Basic Weighted Avg Shares | 69.2 | 42.2 | 31.6 | 23.8 | 15.6 | 0.9 | — |
| Diluted Weighted Avg Shares | 69.2 | 42.2 | 31.6 | 23.8 | 15.6 | 0.9 | — |
| Supplemental | |||||||
| EBITDA | — | (92.2) | (96.2) | (83.6) | (67.8) | (26.9) | — |
| EBIT | (76.2) | (93.6) | (97.7) | (84.8) | (68.3) | (27.1) | — |
| Effective Tax Rate | — | — | — | -0.1% | -5.7% | 0.0% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.